|
0
|
|
Rise of Neisseria gonorrhoeae with mosaic penA-34, France, 2018-2023.
(journals.asm.org)
|
Camelena F
…
Bercot B
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#surveillance
#infection
#sequencing
|
|
0
|
|
Adjunctive povidone-iodine for Acanthamoeba keratitis: a randomized trial.
(journals.asm.org)
|
Rajaraman R
…
Keenan JD
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#infection
#keratitis
#treatment
#amr
|
|
0
|
|
In vitro selection and characterization of resistance to pristinamycin in Mycoplasma genitalium.
(journals.asm.org)
|
Le Roy C
…
Pereyre S
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#sequencing
#infection
|
|
0
|
|
Establishment of epidemiological cutoff values for clinically relevant Sporothrix species using CLSI-broth microdilution.
(journals.asm.org)
|
Dos Santos AR
…
Dufresne PJ
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#antifungal
#susceptibility
#sporotrichosis
#surveillance
#amr
|
|
0
|
|
Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile".
(journals.asm.org)
|
Fabrizio C
…
Tascini C
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#sequencing
#infection
|
|
0
|
|
Identification and characteristics of a novel acquired aminoglycoside phosphotransferase, APH(3')-IVb, from Riemerella anatipestifer.
(journals.asm.org)
|
Zhou M
…
Zhu D
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#sequencing
#plasmid
#conjugation
|
|
0
|
|
Case Commentary: When one target is not enough-PBP3 insertions and target redundancy in Escherichia coli.
(journals.asm.org)
|
Stellfox ME
…
Doi Y
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#infection
#antibiotic
|
|
0
|
|
Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen Candida glabrata reveals the niche-specific requirement for FKS1 and FKS2 during infection and gut colonization.
(journals.asm.org)
|
Arastehfar A
…
Perlin DS
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#virulence
#infection
#colonization
#transcriptomics
|
|
0
|
|
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections.
(journals.asm.org)
|
Karaba SM
…
Tamma PD
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#infection
#bactericidal
|
|
0
|
|
Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants.
(journals.asm.org)
|
Morita J
…
Uchida N
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#pharmacokinetics
#clinical trial
#safety
#amr
|
|
0
|
|
Ceftazidime-avibactam resistance evolution in Pseudomonas aeruginosa and implications for cross-resistance to other novel beta-lactams.
(journals.asm.org)
|
Dorazio AJ
…
Shields RK
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#infection
|
|
0
|
|
Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/beta-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.
(journals.asm.org)
|
Perez-Rodriguez G
…
Arca-Suarez J
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#plasmid
#outbreak
#genomics
|
|
0
|
|
Prevalence and genetics of cefepime resistance among the AmpC-producing organisms Citrobacter freundii complex, Enterobacter cloacae complex, and Klebsiella aerogenes.
(journals.asm.org)
|
Schrader SM
…
Pecora ND
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#genomics
#infection
|
|
0
|
|
Benzoxaborole-modified azithromycins inhibit translation without inducing ermC expression.
(journals.asm.org)
|
Volynkina IA
…
Sergiev PV
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#translation
#ribosome
#antibiotic
|
|
0
|
|
Identification and characteristics of a novel fosfomycin glutathione transferase, FosA12, from an MDR clinical isolate of Proteus vulgaris.
(journals.asm.org)
|
Lu W
…
Wu S
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#sequencing
#infection
|
|
0
|
|
Use of baloxavir as adjunctive antiviral therapy to neuraminidase inhibitors in severely immunocompromised individuals infected with influenza.
(journals.asm.org)
|
Vetter P
…
Neofytos D
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#influenza
#antiviral
#immunocompromised
#infection
#amr
|
|
0
|
|
Single point mutations in global regulatory genes restore cephalosporin resistance in a low-MIC Enterococcus faecium natural isolate.
(journals.asm.org)
|
Sanchez-Osuna M
…
Pich OQ
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#mutation
#transcriptomics
#infection
|
|
0
|
|
Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for Mycobacterium abscessus lung disease.
(journals.asm.org)
|
Singh S
…
Srivastava S
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#pharmacokinetics
#infection
#amr
#tb
|
|
0
|
|
Piperacillin-tazobactam resistance in Klebsiella pneumoniae is often associated with IS26-mediated bla(SHV-1) amplification in a widespread Klebsiella-adapted plasmid.
(journals.asm.org)
|
Royer G
…
Jacquier H
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#plasmid
#sequencing
#transposon
|
|
0
|
|
Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC.
(journals.asm.org)
|
Krankel L
…
Slavetinsky C
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#sepsis
#genomics
#virulence
#evolution
|
|
0
|
|
Dynamic architecture of mycobacterial outer membranes revealed by all-atom simulations.
(elifesciences.org)
|
Brown TP
…
Im W
eLife
2026-05-06
|
#tb
#modeling
#amr
#virulence
|
|
0
|
|
Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinum.
(journals.asm.org)
|
Poonawala H
…
Aldridge BB
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#susceptibility
#amr
#mycobacteria
#infection
#mic
|
|
0
|
|
Classification of outcomes in antimalarial therapeutic efficacy studies with Aster.
(journals.asm.org)
|
Gerlovina I
…
Greenhouse B
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#genotyping
#antimalarial
#sequencing
#classification
|
|
0
|
|
Bridging clinical and environmental reservoirs: antimicrobial resistance in the emerging pathogen Shewanella algae.
(journals.asm.org)
|
Garcia-Rivera C
…
Lopez-Perez M
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#phylogenomics
#emerging pathogen
#environmental reservoir
|
|
0
|
|
Comparative in vitro activity of aztreonam-avibactam and aztreonam plus ceftazidime-avibactam against Stenotrophomonas maltophilia complex.
(journals.asm.org)
|
Kunz Coyne AJ
…
Do A
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#bactericidal
#pharmacodynamics
#antibiotic
|
|
0
|
|
Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant Escherichia coli.
(journals.asm.org)
|
Shropshire WC
…
Shelburne S
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#genomics
#plasmid
#infection
#sequencing
|
|
0
|
|
Comparative in vitro efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-beta-lactamase-producing Enterobacterales isolated in 2024 in France.
(journals.asm.org)
|
Emeraud C
…
Dortet L
Antimicrobial Agents and Chemotherapy
2026-05-06
|
#amr
#infection
#antibiotic
#susceptibility
|